Global Skin Microbiome Market, By Type (Resident Microorganisms, Transient Bacteria), Skin Site (Dry, Moist, Oily), Diseases (Acne Vulgaris, Atopic Dermatitis, Psoriasis Vulgaris, Rosacea) – Industry Trends and Forecast to 2029
Market Analysis and Size
Microbiome research on the skin aims to better understand the body's largest organ by revealing how a host organism evolves in association with its diverse collection of fungi, bacteria, archaea, and viruses, characterizing the immune system and diagnosing illnesses, and investigating disease etiologies. The introduction of high-throughput sequencing has substantially increased our understanding of the skin microbiome and its health consequences. Humans, for example, are now known to be colonized by skin microbial populations that are connected to food, age, and the specific body location examined. These baseline data are critical for determining how the skin's microbiota affects skin health and disease.
Data Bridge Market Research analyses that the skin microbiome market which was USD 699.27 million in 2021, would rocket up to USD 1950.38 million by 2029, and is expected to undergo a CAGR of 13.68% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Resident Microorganisms, Transient Bacteria), Skin Site (Dry, Moist, Oily), Diseases (Acne Vulgaris, Atopic Dermatitis, Psoriasis Vulgaris, Rosacea)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Aurelia Skincare Ltd. (UK), Gallinée (London), Mother Dirt (US), Esse Skincare (South Africa), S-Biomedic (US), Elizabeth Arden (Switzerland), Yun Perobiotherapy (Belgium), TULA Life, Inc. (US), The Beauty Chef (Australia), L’Oreal Paris (France), Clinique Laboratories, llc. (US), La Roche-Posay (US), Tomorrow’s Leaf (U.S), BEBE & BELLA, LLC. (US), ILDONG PHARMACEUTICAL CO.,LTD. (South Korea), AmorePacific (South Korea), LACTOClear (South Korea), BELANO medical AG (Germany), Interpharma Group (Thailand), Glowbiotics LLC (US), Börlind Gesellschaft für kosmetische Erzeugnisse mbH (Germany)
|
|
Market Opportunities
|
|
Market Definition
Skin microbiomes are bacteria that live on the surface of the skin. Skin microflora and skin microbiota are other terms for them. They are usually comparable to the human cells found in our bodies. Microbiome is a vital functional element in skincare that helps with acne, wrinkles, and blemishes, among other skin issues. Microbiome has been studied in the skincare sector to improve skin function and appearance, and research projects are developing microbiome-based remedies for specific skin disorders. Microbiome has been classified as "bioactive components" in skincare products to help improve the appearance and function of the skin. Probiotics, Prebiotics, Postbiotics, and Others are the most common microbiome-based products.
Skin Microbiome Market Dynamics
Drivers
- Protection of skin
The factors which are projected to boost market growth due to their capacity to protect the skin from harmful organisms. Other factors such as their ability to control skin pH, create essential skin nutrients and lipids, and make skin seem healthier and more resilient will propel the skin microbiome market forward during the forecast period of 2022 to 2029.
- Growing skincare products
The worldwide microbiome skincare market will be driven by shifting trends towards microbiome skincare products as a result of the growing popularity of probiotic skincare products. Furthermore, increasing technical advancements and the introduction of new customised goods derived from natural ingredients are some of the key drivers predicted to drive market growth throughout the forecast period.
- Technological innovations
Rapid advancements in the skincare sector have identified the skin microbiota as a stimulating therapeutic approach in skin illnesses including psoriasis and acne vulgaris. Microbiome has been classified as "bioactive components" in skincare products to help improve the appearance and function of the skin. Probiotics, Prebiotics, Postbiotics, and Others are all microbiome-based products.
- Increasing awareness in the society
Growing public awareness about personal care and rising skin disorders linked to cosmetics have increased demand for organic goods over chemical products, which is expected to drive the market during the forecast period.
Opportunities
Technological advancements in the pharmaceutical and cosmetic industries, high prevalence of skin diseases such as eczema, psoriasis, and acne, rising demand for organic skincare products, increasing preference for personal care, rising R&D initiatives to develop microbiome based skincare products, and an ageing population are all expected to drive market growth in the coming years.
Restraints/Challenges
During the projected period, the risk of skin infections is expected to limit market growth. However, over the projected period, the high cost of skin microbiome products and insufficient knowledge of microbe-derived goods are expected to impede market growth.
This skin microbiome market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the skin microbiome market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In December 2020, Mother Dirt (US), a probiotic skincare pioneer, has released reformulated probiotic system kits that include the proprietary AOB (Ammonia Oxidizing Bacteria). The active ingredient in Mother Dirt's AO+ Restorative Mist is AOB.
Global Skin Microbiome Market Scope
The skin microbiome market is segmented on the basis of type, skin site and diseases. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Resident Microorganisms
- Transient Bacteria
Skin Site
- Dry
- Moist
- Oily
Diseases
- Acne Vulgaris
- Atopic Dermatitis
- Psoriasis Vulgaris
Skin Microbiome Market Regional Analysis/Insights
The skin microbiome market is analysed and market size insights and trends are provided by country, type, skin site and diseases as referenced above.
The countries covered in the skin microbiome market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominating the market and is expected to dominate over the forecast years, followed by Europe due to the increasing healthcare expenditure and well-established healthcare infrastructure.
Asia-Pacific is estimated to be the fastest-growing region of this market due to the high prevalence of skin problems and growing awareness among people about personal care.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Skin Microbiome Market Share Analysis
The skin microbiome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to skin microbiome market.
Some of the major players operating in the skin microbiome market are:
- Aurelia Skincare Ltd. (UK)
- Gallinée (London)
- Mother Dirt (US)
- Esse Skincare (South Africa)
- S-Biomedic (US)
- Elizabeth Arden (Switzerland)
- Yun Perobiotherapy (Belgium)
- TULA Life, Inc. (US)
- The Beauty Chef (Australia)
- L’Oreal Paris (France)
- Clinique Laboratories, llc. (US)
- La Roche-Posay (US)
- Tomorrow’s Leaf (US)
- BEBE & BELLA, LLC. (US)
- ILDONG PHARMACEUTICAL CO.,LTD. (South Korea)
- AmorePacific (South Korea)
- LACTOClear (South Korea)
- BELANO medical AG (Germany)
- Interpharma Group (Thailand)
- Glowbiotics LLC (US)
- Börlind Gesellschaft für kosmetische Erzeugnisse mbH (Germany)
SKU-